Genedrive, One Health Issue Millions New Shares on AIM

Several companies listed on the AIM market have announced the issuance and admission of new ordinary shares following the exercise of warrants or share options. Genedrive plc confirmed the exercise of warrants related to an Equity Prepayment facility, leading to the admission of over 4.7 million new shares, expanding the total issued share capital to over 1 billion shares. One Health Group plc issued approximately 21,885 new shares under its EMI Share Option Plan, increasing its total shares to about 13.7 million, reflecting ongoing growth and NHS service provision. Bezant Resources issued 72 million new shares from the exercise of warrants priced at 0.04p per share, raising its total share capital to nearly 16.8 billion shares. These share issuances are expected to be admitted and commence trading around October 30, 2025, with each company highlighting their updated share capital figures for shareholder reference under FCA rules.